| 0.3999 Data as of May 24 | Today’s Change | 0.21 Today|||52-Week Range 0.48 | +37.90% Year-to-Date |
The 1 analysts offering 12-month price forecasts for Aeolus Pharmaceuticals Inc have a median target of 1.25, with a high estimate of 1.25 and a low estimate of 1.25. The median estimate represents a +212.58% increase from the last price of 0.40.

The current consensus among 1 polled investment analysts is to Buy stock in Aeolus Pharmaceuticals Inc. This rating has held steady since May, when it was unchanged from a rating.Move your mouse over past
months for detail

Move your mouse over a quarter or year to see how estimates have changed over time.




